Erratum to: Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials (Endocrine, (2014), 47, 758-763, DOI 10.1007/s12020-014-0298-7);Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Endocrine

Volumn 47, Issue 3, 2014, Pages 758-763

  Mao, Song ^a   Zhang, Aihua ^a   Huang, Songming ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Meta analysis; Selenium

Indexed keywords

SELENIUM;

AGE; ARTICLE; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL VALUE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; RISK ASSESSMENT; DIABETES MELLITUS, TYPE 2;

DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SELENIUM;

EID: 84911954367     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0794-4     Document Type: Erratum

References (28)

1. N. Jafari, Z. Farajzadegan, A. Loghmani, M. Majlesi, N. Jafari, Spiritual well-being and quality of life of Iranian adults with type 2 diabetes. Evid. Based Complement. Altern. Med. 2014, 619028 (2014)
2. P. Zimmet, K.G. Alberti, J. Shaw, Global and societal implications of the diabetes epidemic. Nature 414, 782–787 (2001)
3. K. Imam, Management and treatment of diabetes mellitus. Adv. Exp. Med. Biol. 771, 356–380 (2012)
4. A. Ceriello, E. Motz, Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24, 816–823 (2004)
5. Y. Xia, K.E. Hill, D.W. Byrne, J. Xu, R.F. Burk, Effectiveness of selenium supplements in a low-selenium area of China. Am. J. Clin. Nutr. 81, 829–834 (2005)
6. Z.W. Liu, H.T. Zhu, K.L. Chen, C. Qiu, K.F. Tang, X.L. Niu, Selenium attenuates high glucose-induced ROS/TLR-4 involved apoptosis of rat cardiomyocyte. Biol. Trace Elem. Res. 156, 262–270 (2013)
7. A.S. Müller, E. Most, J. Pallauf, Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice. J. Anim. Physiol. Anim. Nutr. (Berl) 89, 94–104 (2005)
8. J. Zhou, K. Huang, X.G. Lei, Selenium and diabetes—evidence from animal studies. Free Radic. Biol. Med. 584, 343–352 (2013)
9. M.S. Zeng, X. Li, Y. Liu, H. Zhao, J.C. Zhou, K. Li, J.Q. Huang, L.H. Sun, J.Y. Tang, X.J. Xia, K.N. Wang, X.G. Lei, A high-selenium diet induces insulin resistance in gestating rats and their offspring. Free Radic. Biol. Med. 52, 1335–1342 (2012)
10. C. Kornhauser, J.R. Garcia-Ramirez, K. Wrobel, E.L. Pérez-Luque, M.E. Garay-Sevilla, K. Wrobel, Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients. Prim. Care Diabetes 2, 81–85 (2008)
11. S. Stranges, J.R. Marshall, R. Natarajan, R.P. Donahue, M. Trevisan, G.F. Combs, F.P. Cappuccio, A. Ceriello, M.E. Reid, Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Intern. Med. 147, 217–223 (2007)
12. H. Misu, T. Takamura, H. Takayama, H. Hayashi, N. Matsuzawa-Nagata, S. Kurita, K. Ishikura, H. Ando, Y. Takeshita, T. Ota, M. Sakurai, T. Yamashita, E. Mizukoshi, T. Yamashita, M. Honda, K. Miyamoto, T. Kubota, N. Kubota, T. Kadowaki, H.J. Kim, I.K. Lee, Y. Minokoshi, Y. Saito, K. Takahashi, Y. Yamada, N. Takakura, S. Kaneko, A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 12, 483–495 (2010)
13. A.M. Algotar, M.S. Stratton, S.P. Stratton, C.H. Hsu, F.R. Ahmann, No effect of selenium supplementation on serum glucose levels in men with prostate cancer. Am. J. Med. 123, 765–768 (2010)
14. E.A. Klein, I.M. Thompson Jr, C.M. Tangen, J.J. Crowley, M.S. Lucia, P.J. Goodman, L.M. Minasian, L.G. Ford, H.L. Parnes, J.M. Gaziano, D.D. Karp, M.M. Lieber, P.J. Walther, L. Klotz, J.K. Parsons, J.L. Chin, A.K. Darke, S.M. Lippman, G.E. Goodman, F.L. Meyskens Jr, L.H. Baker, Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 306, 1549–1556 (2011)
15. D.D. Karp, S.J. Lee, S.M. Keller, G.S. Wright, S. Aisner, S.A. Belinsky, D.H. Johnson, M.R. Johnston, G. Goodman, G. Clamon, G. Okawara, R. Marks, E. Frechette, W. McCaskill-Stevens, S.M. Lippman, J. Ruckdeschel, F.R. Khuri, Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. J. Clin. Oncol. 31, 4179–4187 (2013)
16. M.P. Rayman, S. Stranges, Epidemiology of selenium and type 2 diabetes: can we make sense of it? Free Radic. Biol. Med. 65, 1557–1564 (2013)
17. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, PRISMA Group, preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 8, 336–341 (2010)
18. C.M. da Costa Santos, C.A. de Mattos Pimenta, M.R. Nobre, The PICO strategy for the research question construction and evidence search. Rev. Lat. Am. Enfermagem 15, 508–511 (2007)
19. L.V. Papp, A. Holmgren, K.K. Khanna, Selenium and selenoproteins in health and disease. Antioxid. Redox Signal. 12, 793–795 (2010)
20. S.R. Stapleton, Selenium: an insulin-mimetic. Cell. Mol. Life Sci. 57, 1874–1879 (2000)
21. H. Misu, T. Takamura, H. Takayama, H. Hayashi, N. Matsuzawa-Nagata, S. Kurita, K. Ishikura, H. Ando, Y. Takeshita, T. Ota, M. Sakurai, T. Yamashita, E. Mizukoshi, T. Yamashita, M. Honda, K. Miyamoto, T. Kubota, N. Kubota, T. Kadowaki, H.J. Kim, I.K. Lee, Y. Minokoshi, Y. Saito, K. Takahashi, Y. Yamada, N. Takakura, S. Kaneko, A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab. 12, 483–495 (2010)
22. T.N. Akbaraly, J. Arnaud, M.P. Rayman, I. Hininger-Favier, A.M. Roussel, C. Berr, A. Fontbonne, Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study. Nutr. Metab. (Lond) 7, 21 (2010)
23. X. Yan, M.P. Pepper, M.Z. Vatamaniuk, C.A. Roneker, L. Li, X.G. Lei, Dietary selenium deficiency partially rescues type 2 diabetes-like phenotypes of glutathione peroxidase-1- overexpressing male mice. J. Nutr. 142, 1975–1982 (2012)
24. M.P. Rayman, G. Blundell-Pound, R. Pastor-Barriuso, E. Guallar, H. Steinbrenner, S. Stranges, A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin. PLoS One 7, e45269 (2012)
25. X.M. Luo, H.J. Wei, C.L. Yang, J. Xing, X. Liu, C.H. Qiao, Y.M. Feng, J. Liu, Y.X. Liu, Q. Wu, Bioavailability of selenium to residents in a low-selenium area of China. Am. J. Clin. Nutr. 42, 439–448 (1985)
26. Y. Xia, Y. Zhao, X. Zhao, L. Zhu, P.D. Whanger, Metabolism of selenate and selenomethionine by a selenium-deficient population of men in China. J. Nutr. 3, 202–210 (1992)
27. G. Forte, B. Bocca, A. Peruzzu, F. Tolu, Y. Asara, C. Farace, R. Oggiano, R. Madeddu, Blood metals concentration in type 1 and type 2 diabetics. Biol. Trace Elem. Res. 156, 79–90 (2013)
28. S. Praveena, S. Pasula, K. Sameera, Trace elements in diabetes mellitus. J. Clin. Diagn. Res. 7, 1863–1865 (2013)